Hudson Bay Capital Management’s Coherus Oncology CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.88M	Buy	1,704,980 +869,980	+104%	+$1.54M	0.02%	670
2025 Q4	$1.19M	Buy	835,000 +25,000	+3%	+$36.4K	0.01%	779
2025 Q3	$1.33M	Sell	810,000 -25,000	-3%	-$27.8K	0.01%	814
2025 Q2	$611K	Hold	835,000	–	–	﹤0.01%	1048
2025 Q1	$674K	Hold	835,000	–	–	﹤0.01%	987
2024 Q4	$1.15M	Buy	835,000 +50,000	+6%	+$56.1K	0.01%	724
2024 Q3	$816K	Hold	785,000	–	–	0.01%	695
2024 Q2	$1.36M	Buy	785,000 +85,000	+12%	+$171K	0.01%	575
2024 Q1	$1.67M	Buy	700,000 +115,000	+20%	+$283K	0.01%	485
2023 Q4	$1.95M	Buy	585,000 +175,000	+43%	+$469K	0.02%	461
2023 Q3	$1.53M	Sell	410,000 -27,500	-6%	-$127K	0.01%	517
2023 Q2	$1.87M	Buy	437,500 +287,500	+192%	+$1.7M	0.02%	516
2023 Q1	$1.03M	Hold	150,000	–	–	0.01%	587
2022 Q4	$1.19M	Buy	+150,000	New	+$1.15M	0.01%	672
2022 Q3	–	Sell	-155,000	Closed	-$1.12M	–	1241
2022 Q2	$1.12M	Buy	+155,000	New	+$1.35M	0.01%	904
2021 Q4	–	Sell	-30,000	Closed	-$482K	–	1105
2021 Q3	$482K	Sell	30,000 -55,000	-65%	-$806K	0.01%	824
2021 Q2	$1.18M	Sell	85,000 -7,500	-8%	-$106K	0.01%	707
2021 Q1	$1.35M	Buy	+92,500	New	+$1.57M	0.02%	639
2020 Q4	–	Sell	-45,000	Closed	-$825K	–	611
2020 Q3	$825K	Sell	45,000 -25,000	-36%	-$465K	0.01%	442
2020 Q2	$1.25M	Buy	70,000 +25,000	+56%	+$423K	0.02%	361
2020 Q1	$730K	Buy	45,000 +4,660	+12%	+$86.1K	0.02%	356
2019 Q4	$726K	Buy	+40,340	New	+$744K	0.02%	331
2019 Q1	–	Sell	-100,000	Closed	-$905K	–	723
2018 Q4	$905K	Buy	+100,000	New	+$1.16M	0.03%	648
2018 Q2	–	Sell	-23,035	Closed	-$255K	–	808
2018 Q1	$255K	Buy	+23,035	New	+$252K	0.01%	718
2015 Q4	–	Sell	-145,261	Closed	-$2.91M	–	193
2015 Q3	$2.91M	Buy	+145,261	New	+$4.42M	0.19%	101